Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaeb conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age

Combination vaccines improve parental and provider satisfaction and schedule compliance by decreasing the number of injections. In a Phase 2, randomized, double-blind, multicenter study, we compared four formulations of a liquid, hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovir...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Vaccine 2009-04, Vol.27 (19), p.2540
Hauptverfasser:	Halperin, Scott A, Tapiero, Bruce, Diaz-Mitoma, Francisco, Law, Barbara J, Hoffenbach, Agnes, Zappacosta, Pamela S, Radley, David, McCarson, Barbara J, Martin, Jason C, Brackett, Laura E, Boslego, John W, Hesley, Teresa M, Bhuyan, Prakash K, Silber, Jeffrey L
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Antigens Children & youth Diphtheria Hepatitis HIV Human immunodeficiency virus Immunization Immunogenicity Laboratories Tetanus Vaccines Whooping cough
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!